These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24655984)

  • 1. Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience.
    Hatakeyama S; Fujita T; Murakami R; Suzuki Y; Sugiyama N; Yamamoto H; Okamoto A; Imai A; Tobisawa Y; Yoneyama T; Mori K; Yoneyama T; Hashimoto Y; Koie T; Narumi S; Ohyama C
    Transplant Proc; 2014; 46(2):445-8. PubMed ID: 24655984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO-incompatible pediatric kidney transplantation without antibody removal.
    Kawamura T; Hamasaki Y; Takahashi Y; Hashimoto J; Kubota M; Muramatu M; Itabashi Y; Hyodo Y; Ohashi Y; Aikawa A; Sakai K; Shishido S
    Pediatr Nephrol; 2020 Jan; 35(1):95-102. PubMed ID: 31673829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.
    Hamano I; Hatakeyama S; Fujita T; Murakami R; Hamaya T; Togashi K; Suzuki Y; Yamamoto H; Yoneyama T; Yoneyama T; Hashimoto Y; Narumi S; Tomita H; Ohyama C
    Transplant Proc; 2020; 52(6):1700-1704. PubMed ID: 32448659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience.
    Habicht A; Bröker V; Blume C; Lorenzen J; Schiffer M; Richter N; Klempnauer J; Haller H; Lehner F; Schwarz A
    Nephrol Dial Transplant; 2011 Dec; 26(12):4124-31. PubMed ID: 21622990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up.
    Genberg H; Kumlien G; Wennberg L; Berg U; Tydén G
    Transplantation; 2008 Jun; 85(12):1745-54. PubMed ID: 18580466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab.
    Genberg H; Kumlien G; Wennberg L; Tydén G
    Transplantation; 2007 Dec; 84(12 Suppl):S44-7. PubMed ID: 18162990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological and Extended Clinical Outcomes After ABO-Incompatible Renal Transplantation Without Splenectomy or Rituximab.
    Chow KV; Flint SM; Shen A; Landgren A; Finlay M; Murugasu A; Masterson R; Hughes P; Cohney SJ
    Transplantation; 2017 Jun; 101(6):1433-1440. PubMed ID: 27495772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of antigen-specific immunoadsorption and rebound of anti-A/B antibodies in ABO-incompatible kidney transplantation.
    Genberg H; Kumlien G; Wennberg L; Tyden G
    Nephrol Dial Transplant; 2011 Jul; 26(7):2394-400. PubMed ID: 21558429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era.
    Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Kang SH; Jung BH; Yoon YI; Kim N
    J Hepatol; 2014 Sep; 61(3):575-82. PubMed ID: 24801413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful launch of an ABO-incompatible kidney transplantation program to overcome the shortage of compatible living donors: experience at a single center
.
    Song SH; Lee J; Kim BS; Kim S; Lee JG; Jeong HJ; Kim YS; Kim MS; Kim HO; Kim SI; Huh KH
    Clin Nephrol; 2017 Sep; 88(9):117-123. PubMed ID: 28679466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Pediatric ABO-incompatible Living Kidney Transplantations From 2002 to 2015: An Analysis of the Japanese Kidney Transplant Registry.
    Hattori M; Mieno M; Shishido S; Aikawa A; Ushigome H; Ohshima S; Takahashi K; Hasegawa A;
    Transplantation; 2018 Nov; 102(11):1934-1942. PubMed ID: 29781948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoagglutinin adsorption in ABO-incompatible transplantation.
    Genberg H; Kumlien G; Wennberg L; Tydén G
    Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation.
    Lee J; Lee JG; Kim S; Song SH; Kim BS; Kim HO; Kim MS; Kim SI; Kim YS; Huh KH
    Nephrol Dial Transplant; 2016 Jun; 31(6):1013-21. PubMed ID: 27190360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center.
    Melexopoulou C; Marinaki S; Liapis G; Skalioti C; Gavalaki M; Zavos G; Boletis JN
    World J Transplant; 2015 Dec; 5(4):329-37. PubMed ID: 26722661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience.
    Shirakawa H; Ishida H; Shimizu T; Omoto K; Iida S; Toki D; Tanabe K
    Clin Transplant; 2011; 25(6):878-84. PubMed ID: 21175849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO-incompatible heart transplantation: analysis of the Pediatric Heart Transplant Study (PHTS) database.
    Henderson HT; Canter CE; Mahle WT; Dipchand AI; LaPorte K; Schechtman KB; Zheng J; Asante-Korang A; Singh RK; Kanter KR
    J Heart Lung Transplant; 2012 Feb; 31(2):173-9. PubMed ID: 22305379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
    Yoshimura N; Ushigome H; Matsuyama M; Nobori S; Suzuki T; Sakai K; Okajima H; Okamoto M
    Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
    Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
    Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience.
    Zschiedrich S; Jänigen B; Dimova D; Neumann A; Seidl M; Hils S; Geyer M; Emmerich F; Kirste G; Drognitz O; Hopt UT; Walz G; Huber TB; Pisarski P; Kramer-Zucker A
    Nephrol Dial Transplant; 2016 Apr; 31(4):663-71. PubMed ID: 26610596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent immunosuppression for ABO-incompatible renal transplantation may not be a risk factor for malignancy.
    Yamamoto T; Kawaguchi T; Watarai Y; Tujita M; Hiramitsu T; Nanmoku K; Goto N; Katayama A; Kobayashi T; Uchida K
    Transplant Proc; 2012 Jan; 44(1):210-3. PubMed ID: 22310616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.